Top ▲
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 1 | 1025 | 5q15 | LNPEP | leucyl and cystinyl aminopeptidase | |
Mouse | 1 | 1025 | 17 A3.2 | Lnpep | leucyl/cystinyl aminopeptidase | |
Rat | 1 | 1025 | 1q12 | Lnpep | leucyl and cystinyl aminopeptidase |
Database Links ![]() |
|
Specialist databases | |
MEROPS | M01.011 (Hs) |
Other databases | |
Alphafold | Q9UIQ6 (Hs), Q8C129 (Mm), P97629 (Rn) |
BRENDA | 3.4.11.3 |
ChEMBL Target | CHEMBL2693 (Hs), CHEMBL4105715 (Mm), CHEMBL3712 (Rn) |
Ensembl Gene | ENSG00000113441 (Hs), ENSMUSG00000023845 (Mm), ENSRNOG00000055229 (Rn) |
Entrez Gene | 4012 (Hs), 240028 (Mm), 171105 (Rn) |
Human Protein Atlas | ENSG00000113441 (Hs) |
KEGG Enzyme | 3.4.11.3 |
KEGG Gene | hsa:4012 (Hs), mmu:240028 (Mm), rno:171105 (Rn) |
OMIM | 151300 (Hs) |
Pharos | Q9UIQ6 (Hs) |
RefSeq Nucleotide | NM_005575 (Hs), NM_175920 (Hs), NM_172827 (Mm), NM_001113403 (Rn), NM_133574 (Rn) |
RefSeq Protein | NP_787116 (Hs), NP_005566 (Hs), NP_766415 (Mm), NP_001106874 (Rn), NP_598258 (Rn) |
UniProtKB | Q9UIQ6 (Hs), Q8C129 (Mm), P97629 (Rn) |
Wikipedia | LNPEP (Hs) |
Enzyme Reaction ![]() |
||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immuno Process Associations | ||
|
||
|
General Comments |
Leucyl/cystinyl aminopeptidase (LNPEP) is a zinc-dependent aminopeptidase that cleaves vasopressin, oxytocin, lys-bradykinin, met-enkephalin, dynorphin A and other peptide hormones. The protein is found as a secreted form, in intracellular vesicles with the insulin-responsive glucose transporter GLUT4 or as a type II membrane-bound glycoprotein. The protein catalyzes the final step in the conversion of angiotensinogen to angiotensin IV (AT4), and AT4 analogues are being investigated as LNPEP inhibitors. |
1. Andersson H, Demaegdt H, Johnsson A, Vauquelin G, Lindeberg G, Hallberg M, Erdelyi M, Karlen A, Hallberg A. (2011) Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis. J Med Chem, 54 (11): 3779-92. [PMID:21476495]
2. Papakyriakou A, Zervoudi E, Theodorakis EA, Saveanu L, Stratikos E, Vourloumis D. (2013) Novel selective inhibitors of aminopeptidases that generate antigenic peptides. Bioorg Med Chem Lett, 23 (17): 4832-6. [PMID:23916253]
M1: Aminopeptidase N: Leucyl-cysteinyl aminopeptidase. Last modified on 11/08/2015. Accessed on 01/05/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=1570.